N/A (device / behavioral)RecruitingNCT06236607
Hybrid closed-loop effectiveness in adults
Adult hybrid-closed-loop effectiveness trial in type 1 diabetes.
Primary endpoints
- Glucose time-in-range (TIR) of 70-180 mg/dL
Results so far
No results posted yet.